Key result
US ischemic heart disease mortality fell by ~58% between 1999 and 2023, though disparities persist.
Why the study?
It remains unclear whether postpandemic ischemic heart disease mortality recovery patterns differ across population subgroups in the United States.
Observational (n=10,200,362)
Although ischemic heart disease mortality in the US has declined substantially from 1999 to 2023, significant geographic, sex, and racial disparities persist, underscoring the necessity for targeted population health and prevention efforts.
Answers are grounded in this paper and cite their sources.
US IHD mortality declined markedly yet disparities endure; extends national surveillance while leaving open targeted equity interventions.
Background Ischemic heart disease (IHD) remains a leading cause of mortality in the United States, yet it remains unclear whether postpandemic recovery patterns differ across population subgroups. Methods Using CDC WONDER data (1999–2023), we analyzed IHD deaths among US adults aged ≥25 years. Age-adjusted mortality rates (AAMRs) were stratified by sex, race/ethnicity, urbanization, and region; crude mortality rates (CMRs) by age. Urban–rural analyses were restricted to 1999–2020. Joinpoint regression estimated temporal trends, and tests of parallelism assessed between-group differences. Results Among 10,200,362 IHD deaths, overall AAMRs declined from 300.8 to 127.07 per 100,000 (average annual percent change, AAPC = −3.51; p < 0.001), with the fastest decline during 2021–2023 (APC = −5.59). Males had higher AAMRs than females (245.58 vs. 138.69; p < 0.001). Non-Hispanic (NH) Black individuals had the highest AAMR (217.58). The steepest age-specific CMR decline occurred at 75–84 years (AAPC = −4.04). Metropolitan areas had lower AAMRs than non-metropolitan areas (189.07 vs. 212.60; p < 0.001). Pairwise tests confirmed significant trend differences across most subgroups (all p < 0.05), except NH Other vs. NH White ( p = 0.396). Conclusions Despite sustained IHD mortality declines, significant disparities persist across demographic and geographic subgroups, supporting targeted prevention for high-risk populations.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted an observational in Ischemic heart disease (n=10,200,362). Calendar year (1999-2023) was evaluated on Age-adjusted mortality rate (AAMR) per 100,000 population (AAPC -3.51, 95% CI -3.99 to -3.03, p=<0.001). Between 1999 and 2023, the overall age-adjusted mortality rate for ischemic heart disease in US adults declined from 300.8 to 127.07 per 100,000 (AAPC -3.51), though demographic disparities persist.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: